TGFBR1 and nonpapillary renal cell carcinoma: Our recent study, on ccRCC, reported that increased expressions of components in canonical TGF-β signaling and in particular AlK5-ICD, a non-canonical pathway component, have a pivotal role in driving the aggressiveness of the tumors, occurrence of metastasis, and survival of the patients [25].